Press release
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting
FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of one abstract for
About this update from Kalvista Pharmaceuticals, Inc.
[{"type":"text","content":" FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--\nKalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of one abstract for late-breaking oral presentation and three for poster presentation at the American College of Allergy, Asthma & Immunology (ACAAI) 2025 Annual Scientific Meeting taking place in Orlando, Florida from November 6–10, 2025.\n\n\nThe lake-breaking oral presentation will take place during Distinguished Industry & Late-breaking Oral Abstracts – Session 1 on Saturday, November 8, in room W230CD:\n\n\n\nSebetralstat for On-demand Treatment of Hereditary Angioedema in Pediatric (2-11y) Patients: Interim Results from KONFIDENT-KID: Adil Adatia, Emel Aygören-Pürsün, Mauro Cancian, Aharon Kessel, H. Henry Li, Heloise Reumaux, H. James Wedner, Erik Hansen, Ya-Hsiu Chuang, Matthew Iverson, Michael D. Smith, Paul K. Audhya, Bob Geng.\n\n\nPresentation time: 5:33 pm ET\n\n\n\n\n\n\nThe three poster presentations will take place during ePosters – Meet the Authors: Session One on Friday, November 7, in West Hall E:\n\n\n\nSatisfaction with Sebetralstat for HAE Attacks in Patients Switching from Parenteral On-demand Treatments in KONFIDENT-S: Maeve E. O'Connor, Michael E. Manning, Inmaculada Martinez-Saguer, Sinisa Savic, Daniel F. Soteres, James Hao, Paolo Bajcic, Paul Audhya, Raffi Tachdjian.\n\n\nPresentation time: 3:05 pm ET\n\n\n\n\n\n\n\nA Delphi Consensus Study on the Barriers to On-Demand Treatment for Hereditary Angioedema Attacks: Aleena Banerji, Jonathan A. Bernstein, Paula J. Busse,Mauro Cancian, Danny M. Cohn, Timothy Craig, Michihiro Hide, William R. Lumry, Marc A. Riedl, Andrea Zanichelli.\n\n\nPresentation time: 4:20 pm ET\n\n\n\n\n\n\n\nHereditary Angioedema Patient and Expert Physician Alignment on a Novel Oral On-demand Therapy: Raffi Tachdjian, John Andersen, William Lumry, Jonathan Bernstein, Maeve O'Connor, Henry Li, Joshua Jacobs, Michael Manning, Daniel Soteres.\n\n\nPresentation time: 5:35 pm ET\n\n\n\n\n\n\nFull session details can be accessed on the ACAAI website. Links to all presentations will be available on the KalVista website under Publications on November 6, 2025.\n\n\nAbout Hereditary Angioedema\nHereditary angioedema (HAE) is a rare genetic disease resulting in deficiency or dysfunction in the C1 esterase inhibitor (C1INH) protein and subsequent uncontrolled ...